Previous close | 0.2706 |
Open | 0.2841 |
Bid | 0.0000 x 1300 |
Ask | 0.0000 x 900 |
Day's range | 0.2706 - 0.2850 |
52-week range | 0.2500 - 6.0000 |
Volume | |
Avg. volume | 1,223,879 |
Market cap | 2.48M |
Beta (5Y monthly) | 1.76 |
PE ratio (TTM) | 0.01 |
EPS (TTM) | 37.1700 |
Earnings date | 09 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Proposed Combination to Focus on Securing Our Nation’s Supply to Critical Materials and ResourcesMINNEAPOLIS, MN, Feb. 14, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), today announced it has entered into a non-binding agreement (“Agreement”) for a proposed merger with M2i Global, Inc. (“M2i,”) (OTC: MTWO), which specializes in the development and execution of a complete global value supply chain for critical minerals for the U.S. government and U.S. free
MINNEAPOLIS, January 25, 2024--FOXO Technologies Inc. (NYSE American: FOXO) (the "Company"), today announced the appointment of Francis Colt deWolf to the Company’s Board of Directors.
MINNEAPOLIS, January 22, 2024--FOXO Technologies Inc. (NYSE American: FOXO) ("FOXO" or the "Company"), a leader in the field of commercializing epigenetic biomarker technology, today announced it has formalized its collaboration with KR8.ai Inc. ("KR8") and secured the exclusive license to KR8’s AI-based software to support the development and commercial launch of its new health and wellness offering - the VITHAR™ AI Health Coach. As previously announced, the Company is in the process of launchi